Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
Clinical trial NCT01451736 · COMPLETED
Trial details
- NCT number
- NCT01451736
- Sponsor
- University of California, Los Angeles
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2021-12-01
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.